Moreover, TMAO upregulates POSTN, NAPB, LAYN, and HTRA3 in liver cancer, and high expression levels of these genes are closely associated with suppression of the immune microenvironment and patient survival outcomes in liver cancer. This evidence concerns the gene NAPB and liver cancer.